Cross-sectional analysis of students and school workers reveals a high number of asymptomatic SARS-CoV-2 infections during school reopening in Brazilian cities
Brazil experienced one of the most prolonged periods of school closures, and reopening could have exposed students to high rates of SARS-CoV-2 infection. However, the infection status of students and school workers at the time of the reopening of schools located in Brazilian cities is unknown. Here we evaluated viral carriage by RT-PCR and seroprevalence of anti-SARS-CoV-2 antibodies (IgM and IgG) by immunochromatography in 2259 individuals (1139 students and 1120 school workers) from 28 schools in 28 Brazilian cities. We collected the samples within 30 days after public schools reopened and before the start of vaccination campaigns. Most students (n = 421) and school workers (n = 446) had active (qRT-PCR + IgM- IgG- or qRT-PCR + IgM + IgG-/+) SARS-CoV-2 infection. Regression analysis indicated a strong association between the infection status of students and school workers. Furthermore, while 45% (n = 515) of the students and 37% (n = 415) of the school workers were neither antigen nor antibody positive in laboratory tests, 16% of the participants (169 students and 193 school workers) were oligosymptomatic, including those reinfected. These individuals presented mild symptoms such as headache, sore throat, and cough. Notably, most of the individuals were asymptomatic (83.9%). These results indicate that many SARS-CoV-2 infections in Brazilian cities during school reopening were asymptomatic. Thus, our study highlights the need to promote a coordinated public health effort to guarantee a safe educational environment while avoiding exacerbating pre-existent social inequalities in Brazil, reducing social, mental, and economic losses for students, school workers, and their families.
Authors
Borges, Lysandro P; Guimari£es, Adriana G; Fonseca, Dennyson Leandro M; Freire, Paula P; Barreto, ikaro DC; Souza, Daniela RV; Gurgel, Ricardo Q; Lopes, Aline SA; de Rezende Neto, Jose Melquiades; Dos Santos, Kezia A;
External link
Publication Year
Publication Journal
Associeted Project
Digital Epidemiology
Lista de serviços
-
Systems vaccinology: its promise and challenge for HIV vaccine development.Systems vaccinology: its promise and challenge for HIV vaccine development.
-
Systems vaccinology: learning to compute the behavior of vaccine induced immunity.Systems vaccinology: learning to compute the behavior of vaccine induced immunity.
-
Systems biology of vaccination in the elderly.Systems biology of vaccination in the elderly.
-
Immunity to viruses: learning from successful human vaccines.Immunity to viruses: learning from successful human vaccines.
-
Systems biological approaches to measure and understand vaccine immunity in humans.Systems biological approaches to measure and understand vaccine immunity in humans.
-
Gene signatures related to B-cell proliferation predict influenza vaccine-induced antibody response.Gene signatures related to B-cell proliferation predict influenza vaccine-induced antibody response.
-
Vaccinology in the era of high-throughput biology.Vaccinology in the era of high-throughput biology.
-
Systems vaccinology: Enabling rational vaccine design with systems biological approaches.Systems vaccinology: Enabling rational vaccine design with systems biological approaches.
-
Systems Vaccinology Applied to DNA Vaccines: Perspective and Challenges.Systems Vaccinology Applied to DNA Vaccines: Perspective and Challenges.
-
Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
-
Methods for predicting vaccine immunogenicity and reactogenicity.Methods for predicting vaccine immunogenicity and reactogenicity.
-
Antigenicity prediction and vaccine recommendation of human influenza virus A (H3N2) using convolutional neural networks.Antigenicity prediction and vaccine recommendation of human influenza virus A (H3N2) using convolutional neural networks.
-
Pneumococcal colonization impairs mucosal immune responses to live attenuated influenza vaccine.Pneumococcal colonization impairs mucosal immune responses to live attenuated influenza vaccine.
-
Human Transcriptomic Response to the VSV-Vectored Ebola Vaccine.Human Transcriptomic Response to the VSV-Vectored Ebola Vaccine.
-
Induction of Cell Cycle and NK Cell Responses by Live-Attenuated Oral Vaccines against Typhoid Fever.Induction of Cell Cycle and NK Cell Responses by Live-Attenuated Oral Vaccines against Typhoid Fever.
-
Systems Biology Analysis of the Radiation-Attenuated Schistosome Vaccine Reveals a Role for Growth Factors in Protection and Hemostasis Inhibition in Parasite Survival.Systems Biology Analysis of the Radiation-Attenuated Schistosome Vaccine Reveals a Role for Growth Factors in Protection and Hemostasis Inhibition in Parasite Survival.
-
Molecular alterations in human milk in simulated maternal nasal mucosal infection with live attenuated influenza vaccinationMolecular alterations in human milk in simulated maternal nasal mucosal infection with live attenuated influenza vaccination
-
Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood.Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood.
-
Systems analysis of protective immune responses to RTS,S malaria vaccination in humans.Systems analysis of protective immune responses to RTS,S malaria vaccination in humans.
-
Systems vaccinology.Systems vaccinology.
-
Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans.Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans.
-
Systems biology of vaccination for seasonal influenza in humans.Systems biology of vaccination for seasonal influenza in humans.
-
Prior upregulation of interferon pathways in the nasopharynx impacts viral shedding following live attenuated influenza vaccine challenge in childrenPrior upregulation of interferon pathways in the nasopharynx impacts viral shedding following live attenuated influenza vaccine challenge in children
-
Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular Signatures.Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular Signatures.
-
Molecular signatures of antibody responses derived from a systems biology study of five human vaccines.Molecular signatures of antibody responses derived from a systems biology study of five human vaccines.
-
Long noncoding RNAs are involved in multiple immunological pathways in response to vaccination.Long noncoding RNAs are involved in multiple immunological pathways in response to vaccination.
-
Metabolic Phenotypes of Response to Vaccination in Humans.Metabolic Phenotypes of Response to Vaccination in Humans.
-
Hidden in plain sight: uncovering the role of CREB1 in HIV-1 vaccine-induced immunityHidden in plain sight: uncovering the role of CREB1 in HIV-1 vaccine-induced immunity
-
Transcriptomic signatures induced by the Ebola virus vaccine rVSV-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker studyTranscriptomic signatures induced by the Ebola virus vaccine rVSV-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study
-
Baseline gene signatures of reactogenicity to Ebola vaccination: a machine learning approach across multiple cohortsBaseline gene signatures of reactogenicity to Ebola vaccination: a machine learning approach across multiple cohorts
-
Global blood miRNA profiling unravels early signatures of immunogenicity of Ebola vaccine rVSVΔG-ZEBOV-GPGlobal blood miRNA profiling unravels early signatures of immunogenicity of Ebola vaccine rVSVΔG-ZEBOV-GP